IDEXX LABORATORIES INC /DE Increase (Decrease) in Other Operating Assets and Liabilities, Net
IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $66.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was $20.14M, a 83.75% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $46.40M, a 389.05% increase year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$4.58M, a 112.95% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was $27.48M, a 57.09% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $156.36M, a 93.84% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was $80.67M.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$13.68M, a 113.30% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $102.85M, a 86.51% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $66.54M 10-Q · filed 2026-08-04 | $61.95M derived: sum of 3 quarters · filed 2026-08-04 | $89.44M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $46.40M 10-Q · filed 2026-05-05 | $41.81M derived: sum of 2 quarters · filed 2026-05-05 | $69.30M derived: sum of 3 quarters · filed 2026-05-05 | $193.27M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $22.90M derived: sum of 2 quarters · filed 2026-02-20 | $146.87M derived: sum of 3 quarters · filed 2026-08-04 | $156.36M 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $27.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $151.46M derived: sum of 2 quarters · filed 2026-08-04 | $160.94M 10-Q · filed 2025-11-03 | $196.34M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $123.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $133.46M 10-Q · filed 2026-08-04 | $139.91M 10-Q · filed 2025-08-04 | $168.85M derived: sum of 3 quarters · filed 2026-08-04 | $232.91M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $9.49M 10-Q · filed 2026-05-05 | $10.32M 10-Q · filed 2025-05-01 | $44.88M derived: sum of 2 quarters · filed 2026-05-05 | $108.94M derived: sum of 3 quarters · filed 2026-05-05 | $68.74M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $35.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $99.45M derived: sum of 2 quarters · filed 2026-02-20 | $59.25M derived: sum of 3 quarters · filed 2026-02-20 | $80.67M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $64.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $23.86M derived: sum of 2 quarters · filed 2025-11-03 | $45.27M 10-Q · filed 2025-11-03 | $13.69M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | -$40.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$18.78M 10-Q · filed 2025-08-04 | -$50.37M derived: sum of 3 quarters · filed 2026-02-20 | -$56.70M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $21.42M 10-Q · filed 2025-05-01 | -$10.17M derived: sum of 2 quarters · filed 2026-02-20 | -$16.50M derived: sum of 3 quarters · filed 2026-02-20 | $2.43M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | -$31.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$37.92M derived: sum of 2 quarters · filed 2026-02-20 | -$18.99M derived: sum of 3 quarters · filed 2026-02-20 | -$13.68M 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | -$6.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $12.60M derived: sum of 2 quarters · filed 2024-10-31 | $17.90M 10-Q · filed 2024-10-31 | $33.19M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $18.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $24.24M 10-Q · filed 2024-08-06 | $39.52M derived: sum of 3 quarters · filed 2025-02-21 | $32.36M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $5.31M 10-Q · filed 2024-05-01 | $20.59M derived: sum of 2 quarters · filed 2025-02-21 | $13.43M derived: sum of 3 quarters · filed 2025-02-21 | $55.25M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $8.12M derived: sum of 2 quarters · filed 2025-02-21 | $49.95M derived: sum of 3 quarters · filed 2025-02-21 | $102.85M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | -$7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $34.66M derived: sum of 2 quarters · filed 2023-11-01 | $87.57M 10-Q · filed 2023-11-01 | $90.75M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $41.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $94.73M 10-Q · filed 2023-08-01 | $97.91M derived: sum of 3 quarters · filed 2024-02-22 | $94.71M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $52.90M 10-Q · filed 2023-05-02 | $56.09M derived: sum of 2 quarters · filed 2024-02-22 | $52.89M derived: sum of 3 quarters · filed 2024-02-22 | $50.97M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$17.00K derived: sum of 2 quarters · filed 2024-02-22 | -$1.94M derived: sum of 3 quarters · filed 2024-02-22 | $55.15M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$5.12M derived: sum of 2 quarters · filed 2022-11-01 | $51.96M 10-Q · filed 2022-11-01 | $22.30M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $55.16M 10-Q · filed 2022-08-02 | $25.50M derived: sum of 3 quarters · filed 2023-02-16 | -$536.00K derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | $57.08M 10-Q · filed 2022-05-04 | $27.42M derived: sum of 2 quarters · filed 2023-02-16 | $1.38M derived: sum of 3 quarters · filed 2023-02-16 | -$68.04M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | -$29.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$55.70M derived: sum of 2 quarters · filed 2023-02-16 | -$125.12M derived: sum of 3 quarters · filed 2023-02-16 | -$60.24M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | -$26.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$95.46M derived: sum of 2 quarters · filed 2021-11-02 | -$30.58M 10-Q · filed 2021-11-02 | -$50.56M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$69.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$4.54M 10-Q · filed 2021-07-30 | -$24.52M derived: sum of 3 quarters · filed 2022-02-16 | -$15.57M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $64.88M 10-Q · filed 2021-05-04 | $44.90M derived: sum of 2 quarters · filed 2022-02-16 | $53.85M derived: sum of 3 quarters · filed 2022-02-16 | $50.07M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$19.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$11.03M derived: sum of 2 quarters · filed 2022-02-16 | -$14.81M derived: sum of 3 quarters · filed 2022-02-16 | $34.79M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $8.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $5.17M derived: sum of 2 quarters · filed 2020-10-29 | $54.77M 10-Q · filed 2020-10-29 | $36.29M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | -$3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $45.82M 10-Q · filed 2020-07-31 | $27.34M derived: sum of 3 quarters · filed 2021-02-12 | $29.77M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $49.60M 10-Q · filed 2020-04-30 | $31.12M derived: sum of 2 quarters · filed 2021-02-12 | $33.55M derived: sum of 3 quarters · filed 2021-02-12 | $37.03M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | -$18.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$16.05M derived: sum of 2 quarters · filed 2021-02-12 | -$12.57M derived: sum of 3 quarters · filed 2021-02-12 | $39.73M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $5.91M derived: sum of 2 quarters · filed 2019-10-31 | $58.21M 10-Q · filed 2019-10-31 | $62.00K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $55.78M 10-Q · filed 2019-08-01 | -$2.37M derived: sum of 3 quarters · filed 2020-02-14 | -$13.06M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $52.30M 10-Q · filed 2019-05-01 | -$5.85M derived: sum of 2 quarters · filed 2020-02-14 | -$16.54M derived: sum of 3 quarters · filed 2020-02-14 | -$33.65M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | -$58.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$68.84M derived: sum of 2 quarters · filed 2020-02-14 | -$85.95M derived: sum of 3 quarters · filed 2020-02-14 | -$47.42M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | -$10.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$27.80M derived: sum of 2 quarters · filed 2018-11-01 | $10.73M 10-Q · filed 2018-11-01 | $10.62M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-06-30 | -$17.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $21.43M 10-Q · filed 2018-08-01 | $21.32M derived: sum of 3 quarters · filed 2019-02-15 | $4.94M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-03-31 | $38.53M 10-Q · filed 2018-05-04 | $38.42M derived: sum of 2 quarters · filed 2019-02-15 | $22.05M derived: sum of 3 quarters · filed 2019-02-15 | $2.29M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$16.48M derived: sum of 2 quarters · filed 2019-02-15 | -$36.24M derived: sum of 3 quarters · filed 2019-02-15 | -$12.49M 10-K · filed 2019-02-15 | -$8.12M 10-K · filed 2017-02-17 | |||
| 2016-09-30 | -$16.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$36.13M derived: sum of 2 quarters · filed 2017-10-31 | -$12.38M 10-Q · filed 2017-10-31 | -$8.65M 10-Q · filed 2016-11-01 | -$19.37M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | -$19.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $3.99M 10-Q · filed 2017-08-01 | $7.73M 10-Q · filed 2016-08-02 | -$2.99M derived: sum of 3 quarters · filed 2018-02-16 | -$14.33M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | $23.75M 10-Q · filed 2017-04-28 | $27.52M 10-Q · filed 2016-04-29 | $16.77M derived: sum of 2 quarters · filed 2018-02-16 | $5.43M derived: sum of 3 quarters · filed 2018-02-16 | -$10.52M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | -$6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$18.32M derived: sum of 2 quarters · filed 2018-02-16 | -$34.27M derived: sum of 3 quarters · filed 2018-02-16 | -$23.52M 10-K · filed 2018-02-16 | -$18.09M 10-K · filed 2016-02-17 | |||
| 2015-09-30 | -$11.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$27.28M derived: sum of 2 quarters · filed 2016-11-01 | -$16.54M 10-Q · filed 2016-11-01 | |||||
| 2015-06-30 | -$15.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$5.20M 10-Q · filed 2016-08-02 | ||||||
| 2015-03-31 | $10.75M 10-Q · filed 2016-04-29 | |||||||
| 2014-12-31 | -$11.32M 10-K · filed 2017-02-17 | |||||||
| 2013-12-31 | -$12.19M 10-K · filed 2016-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |